This activity was originally presented at the 2025 Community Oncology Conference in Lake Buena Vista, Florida on April 30, 2025.
Target audience: Oncology pharmacists and specialty pharmacists
Type of activity: Knowledge
Release date: May 6, 2026
Expiration date: May 6, 2026
Time to complete activity: 0.75 hour
Learner level: Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Define PBM Practices and their Impact – Explain steerage, discuss current reimbursement challenges, and legal actions affecting medically integrated dispensing (MID) pharmacies
- Discuss status of COA public arbitrations - briefly review what has happened and future implications
- Examine Legal and Regulatory Trends - state-driven policies governing pharmacy regulations, licensing variations, and the implications for MIDs/physician-owned practices
- Illustrate oncology pharmacists integration into patient care - discuss the role of pharmacists in clinical decision-making, and strategies to strengthen community oncology teams
- Explore reasons PBM reform absent from End Of Year (EOY) package - conclusions and predictions for PBM reform and pharmacist integration
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
